Top Markets
Coin of the day
Clearmind Medicine Inc. Clearmind Medicine Inc.

Clearmind Medicine Inc.

CMND
Rank in Stocks #35565
Operating as a pre-clinical pharmaceutical firm, Clearmind Medicine Inc.... Operating as a pre-clinical pharmaceutical firm, Clearmind Medicine Inc. specializes in pioneering psychedelic therapies aimed at addressing overlooked medical conditions. Its development efforts encompass treatments for alcohol use disorders, notably binge drinking, various eating disorders, depression, and a spectrum of mental health challenges including binge eating and other compulsive behaviors. Founded in 2017, this Vancouver, Canada-based entity transitioned from its former identity as Cyntar Ventures Inc. to Clearmind Medicine Inc. in March 2021.
Share Price
$1.17
Last synced: 2024-03-14
Market Cap
$3.72M
Change (1 day)
-13.55%
Change (1 year)
0.00%
Country
CA
Trade Clearmind Medicine Inc. (CMND)

Category

EPS for Clearmind Medicine Inc. (CMND)
EPS as of 2026 TTM: 0
According to Clearmind Medicine Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Clearmind Medicine Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE